Facebook Pixel Code
About Sickkids
About SickKids

Ian Kitai, MB, BCh, FRCP(C)

The Hospital for Sick Children
Staff Physician, TB Specialist
Infectious Diseases

University of Toronto
Associate Professor

Other Positions

Rouge Valley Health System
Infection Control
Medical Consultant

Phone: 416-813-6273
Email: ian.kitai@sickkids.ca

Brief Biography

Dr. Kitai trained in Medicine in South Africa, in Paediatrics in the U.K. and Toronto and in Paediatric Infectious Diseases in Toronto. He has worked for three years for Oxfam (U.K.) in rural Zimbabwe and for two years with the Northern Medical Unit of the University of Manitoba. He is currently in consulting paediatric practice in Ajax and is the TB specialist at The Hospital for Sick Children (SickKids) in Toronto. From 2002 to 2006 he was a medical consultant in Infection Control at the Rouge Valley Health System and received the Council award from the College of Physicians and Surgeons of Ontario partly for his work during SARS.

Clinical Care Activities

Paediatric tuberculosis, paediatric infectious diseases and general paediatrics.

Academic Background

University of Witwatersrand, 1972-01-01 - 1977-12-31

Research Interests

Management of paediatric tuberculosis, infection control in a community setting.

Research Activities

  • Clinical presentation of TB at different ages
  • Immunity to TB in children
  • Diagnostic imaging modalities in paediatric TB


2004 - College of Physicians and Surgeons of Ontario Council Award

1991 - The Hospital for Sick Children, Toronto
Odaantjie foundation award for excellence in clinical teaching
Second prize, Tisdall award for excellence in paediatric research


Select recent publications

Kordy F, Waters V, Den Hollander C, Read S, Lam R, Kitai I. Optimizing blood collection and processing for QuantiFERON-TB Gold-In Tube testing gives low rates of indeterminate results: clinical implications. Pediatr Infect Dis J. 2017 Aug 2. doi: 10.1097/INF.0000000000001732. [Epub ahead of print]

Kitai I, Kordy M, Morris S, Lam R.  Diagnosis and management of paediatric tuberculosis in Canada.  CMAJ 2017 January 9;189:E11-6. doi: 10.1503/cmaj.151212 (PA)

Xu  J, Peer S, Papsin B, Kitai I,. Propst EJ.   Tuberculous lymphadenitis of the head and neck in Canadian children: experience from a low-burden region. International Journal of Pediatric Otorhinolaryngology 2016 91:11-

*Rayment J, Guthrie JL. Lee B, Whelan M, Lam K, Jamieson F, Kitai I.  Culture-positive paediatric tuberculosis in Toronto, Ontario: Sources of infection and relationship of birthplace and mycobacterial lineage to phenotype. Pediatr Infect Dis J 2016 Jan: 35:13-8.

Rose W, Read S, Bitnun A, Rea E, Stephens D, Pongsamart W, Kitai I. Relating tuberculosis (TB) contact characteristics to QuantiFERON-TB-Gold and tuberculin skin test results in the Toronto pediatric TB clinic.  J Pediatric Infect Dis Soc. 2015 :96-103

Khan S, Stimec J, Kitai I. Non responding osteomyelitis in a two-year-old boy. Practice, CMAJ. 2015;187:901-4

Morris SK, Demers AM, Lam R, Pell LG, *Giroux R, Kitai I. Epidemiology and clinical management of tuberculosis in children in Canada. Paediatr Child Health. 2015 20: 83-8

Kordy F, Richardson SE, Stephens D, Lam R, Jamieson F, Kitai I. Utility of Gastric Aspirates for Diagnosing Tuberculosis in Children in a Low Prevalence Area: Predictors of Positive Cultures and Significance of Non-Tuberculous Mycobacteria.Pediatr Infect Dis J. 2015 Jan;34(1):91-3

Rose W, Kitai I *Kakkar F, Read S, Bitnun A.  Quantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values. BMC Infectious Diseases 2014, 14:516  doi:10.1186/1471-2334-14-516

Hildebrand K, Atkinson A, Kitai I. Rifampin hypersensitivity in a two-year old child with successful rapid oral desensitization. Pediatr Infect Dis J. 2014 Jul;33(7):787

Kitai I, Morris SK: Encounters with an old foe: Childhood tuberculosis in Canada.  Pediatr Child Health  2014; 89-90.

Kitai I.  Demers AM. Paediatric Tuberculosis.  in Menzies D (ed) Canadian TB Standards, 7th Edition, Public Health Agency of Canada and Canadian Thoracic Society. Prerelease available at http://www.respiratoryguidelines.ca/tb-standards-2013 Canadian Respiratory Journal July/August 2013, Volume 20, Supplement SA     

Science M, Ito S, Kitai I. 1. Isoniazid toxicity in a 5 year old boy. Practice: CMAJ. 2013;185: 894-6

Schwartz K, Al-Rasheed A, Laxer R, Lam R, Kitai I. Monoarthritis in a four year old child. Paediatr Child Health 2012 17: 387-90

Thampi N, Stephens D, Rea E, Kitai I. Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors. Pediatr Infect Dis J. 2012 31:129-33.

Greenaway C, Sandoe A, Vissandjee B, Kitai I, et al.  Tuberculosis: evidence review for newly arriving immigrants and refugees.   CMAJ. 2011: 183 E824-925  

Al-Dabbagh M, Lapprha K, Pattar R, Inrig K, Sauve L, Simon Schaaf H, Marais BJ,  Kitai I and Kollmann TR. Drug-Resistant Tuberculosis: A Review of Pediatric Treatment Guidelines.  Pediatr Infect Dis J. 2011 30:501-505

Kakkar F, Ling D, Pai M, Allen U,  Kitai I (for the Canadian Pediatric Society) Tuberculosis in Children: new diagnostic blood tests. Paediatr Child Health 2010;15(8):529-33

Pau WS, AlSaffar H, Weinstein M, Kitai I. Sporotrichoid-like tuberculosis.  Pediatr Infect Dis J. 2009 28:1135-6.  

Phongsamart W,  Kitai I,  Gardam M,  Wang J,  Khan K N. A population-based study of tuberculosis in children and adolescents in Ontario.  Pediatr Infect Dis J 2009; 28:416-9